Covered recipient · General Payments record
CAROLINE I KOZLOWSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$6,265.93
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,994.57 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,447.09 | 27 |
| REVANCE THERAPEUTICS, INC. | $200.76 | 2 |
| MERZ NORTH AMERICA, INC. | $130.33 | 2 |
| ConvaTec Inc. | $122.57 | 1 |
| Galderma Laboratories, L.P. | $71.95 | 4 |
| Biofrontera Inc. | $21.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $36.18 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484159 | CMS |
| ABBVIE INC. | $25.99 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484161 | CMS |
| ABBVIE INC. | $10.99 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484163 | CMS |
| ABBVIE INC. | $70.76 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484165 | CMS |
| ABBVIE INC. | $149.86 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484167 | CMS |
| ABBVIE INC. | $10.96 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484169 | CMS |
| ABBVIE INC. | $129.01 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484171 | CMS |
| ABBVIE INC. | $124.22 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484173 | CMS |
| ABBVIE INC. | $31.21 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484175 | CMS |
| ABBVIE INC. | $45.37 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484177 | CMS |
| ABBVIE INC. | $7.14 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484179 | CMS |
| ABBVIE INC. | $124.46 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484181 | CMS |
| ABBVIE INC. | $104.05 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484183 | CMS |
| ABBVIE INC. | $83.75 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484185 | CMS |
| ABBVIE INC. | $31.00 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484187 | CMS |
| ABBVIE INC. | $8.46 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484189 | CMS |
| ABBVIE INC. | $6.30 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484191 | CMS |
| ABBVIE INC. | $42.32 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484193 | CMS |
| ABBVIE INC. | $223.31 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484195 | CMS |
| ABBVIE INC. | $11.10 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484197 | CMS |
| ABBVIE INC. | $22.64 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484199 | CMS |
| ABBVIE INC. | $17.45 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484201 | CMS |
| ABBVIE INC. | $13.50 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484203 | CMS |
| ABBVIE INC. | $19.25 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484205 | CMS |
| ABBVIE INC. | $29.70 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484207 | CMS |
| ABBVIE INC. | $33.96 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484209 | CMS |
| ABBVIE INC. | $34.15 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107484211 | CMS |
| Biofrontera Inc. | $21.87 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110849434 | CMS |
| ConvaTec Inc. | $122.57 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151391073 | CMS |
| Galderma Laboratories, L.P. | $21.95 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145369573 | CMS |
| Galderma Laboratories, L.P. | $19.13 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145369575 | CMS |
| Galderma Laboratories, L.P. | $16.29 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145369577 | CMS |
| Galderma Laboratories, L.P. | $14.58 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145369579 | CMS |
| MERZ NORTH AMERICA, INC. | $73.64 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146380326 | CMS |
| MERZ NORTH AMERICA, INC. | $56.69 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146380328 | CMS |
| REVANCE THERAPEUTICS, INC. | $133.26 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147944019 | CMS |
| REVANCE THERAPEUTICS, INC. | $67.50 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147944021 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.